Graviton
Graviton develops novel therapeutics for the treatment of autoimmune, cancer, certain genetic, fibrotic, and other serious diseases.
Graviton operates in biotechnology, therapeutics based in Greater New York Area, East Coast, Northeastern US, founded in 2020.
As a business in biotechnology, therapeutics, Graviton is listed here with the public details available about it.
The company is recorded as being based in Greater New York Area, East Coast, Northeastern US.
Its current recorded stage is Series_Unknown.
Its team size is recorded as c_00011_00050 employees.
It has disclosed roughly $43.3M in funding.
| Sector | Biotechnology, Therapeutics |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Founded | 2020 |
| Employees | c_00011_00050 |
| Stage | series_unknown |
| Total funding | $43,319,496 |
Website: graviton.bio
Sign in to view the contact information we hold for Graviton.
Create a free account
Create a free account